Hahn Jin Jung1, In-Soo Shin2, Ji-Eun Lee3. 1. Department of Otorhinolaryngology-Head and Neck Surgery, Chungbuk National University College of Medicine, Chungbuk National University Hospital, Cheongju, South Korea. 2. College of Education, Jeonju University, Jeonju, South Korea. 3. Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine Chosun University, Gwangju, South Korea.
Abstract
OBJECTIVE: Olfactory function is altered in mild cognitive impairment (MCI) and Alzheimer's disease (AD); therefore, it may serve as a useful tool for the early detection of MCI before its advancement to AD. The aim of this meta-analysis was to investigate olfactory deficits in patients with MCI and AD. STUDY DESIGN: Literature search. METHODS: A search was conducted of the electronic databases PubMed, Embase, and Web of Science from their inception until 2017. We included original articles with adequate data on the identification, threshold, and/or discrimination of olfactory function in MCI or AD. The standard mean difference and 95% confidence interval (CI) were calculated. The studies were weighted according to inverse variance estimates. The effect sizes were categorized as small [Cohen's d = 0.2], medium (d = 0.5), or large (d ≥ 0.8) based on these methods. Subgroup analyses were performed based on mean age and sex differences between the groups. RESULTS: Twelve articles (reporting 21 effects) examining 563 patients with MCI and 788 patients with AD, were included in the meta-analysis. Compared to MCI, AD had moderate to large heterogeneous effects on olfactory function (Cohen's d = 0.64, 95% CI: 0.50, 0.78). Olfactory identification tests demonstrated larger effects (d = 0.71, 95% CI: 0.51, 0.91) than did tests of other olfactory domains. CONCLUSIONS: Meta-analysis results revealed that olfactory identification was more profoundly impaired in patients with AD than in those with MCI. These findings suggest that a simple test of odor identification is valuable in differentiating individuals at a risk of AD. LEVEL OF EVIDENCE: NA Laryngoscope, 129:362-369, 2019.
OBJECTIVE: Olfactory function is altered in mild cognitive impairment (MCI) and Alzheimer's disease (AD); therefore, it may serve as a useful tool for the early detection of MCI before its advancement to AD. The aim of this meta-analysis was to investigate olfactory deficits in patients with MCI and AD. STUDY DESIGN: Literature search. METHODS: A search was conducted of the electronic databases PubMed, Embase, and Web of Science from their inception until 2017. We included original articles with adequate data on the identification, threshold, and/or discrimination of olfactory function in MCI or AD. The standard mean difference and 95% confidence interval (CI) were calculated. The studies were weighted according to inverse variance estimates. The effect sizes were categorized as small [Cohen's d = 0.2], medium (d = 0.5), or large (d ≥ 0.8) based on these methods. Subgroup analyses were performed based on mean age and sex differences between the groups. RESULTS: Twelve articles (reporting 21 effects) examining 563 patients with MCI and 788 patients with AD, were included in the meta-analysis. Compared to MCI, AD had moderate to large heterogeneous effects on olfactory function (Cohen's d = 0.64, 95% CI: 0.50, 0.78). Olfactory identification tests demonstrated larger effects (d = 0.71, 95% CI: 0.51, 0.91) than did tests of other olfactory domains. CONCLUSIONS: Meta-analysis results revealed that olfactory identification was more profoundly impaired in patients with AD than in those with MCI. These findings suggest that a simple test of odor identification is valuable in differentiating individuals at a risk of AD. LEVEL OF EVIDENCE: NA Laryngoscope, 129:362-369, 2019.
Authors: Xiuli Dan; Noah Wechter; Samuel Gray; Joy G Mohanty; Deborah L Croteau; Vilhelm A Bohr Journal: Ageing Res Rev Date: 2021-07-27 Impact factor: 11.788
Authors: Victoria Van Regemorter; Thomas Hummel; Flora Rosenzweig; André Mouraux; Philippe Rombaux; Caroline Huart Journal: Front Neurosci Date: 2020-02-21 Impact factor: 4.677